News
BioNTech SE (NASDAQ:BNTX) is one of the 13 Best German Stocks to Invest in Now. It is a clinical-stage biotechnology company ...
Hosted on MSN10mon
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' - MSNWednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
TJ3 History on MSN5d
How a WWII German Pilot Got Outflanked… by a Grandma!In the midst of the Battle of Britain, a German bomber pilot bails out after his Heinkel He-111 is blasted by flak over ...
The Super Series moved to a new venue this weekend, while British elite athletes were in action at the World Triathlon Cup in Hungary.
Mollie German, Licensed Clinical Mental Health Counselor, Bristol, VT, 05443, (802) 613-0764, Psychotherapy is a collaboration existing within a trusted, safe relationship. We can work together to ...
Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an area of oncology that seeks to harness the immune ...
Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges and outlines cost-cutting measures, including a 7% workforce reduction.
Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results